Search

everythinglearnresearchcommunity

for

Search:↓

Silver nanoparticles from Laurus nobilis leaves may be a new, safer antiarthritic treatment.

Tailoring COVID-19 measures to risk levels in the military improves health and readiness.

Pharmacists play a crucial role in safe medication use and interdisciplinary collaboration is key to reducing antimicrobial resistance.

Both photobiomodulation and low-frequency treatments effectively reduce body measurements.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Many patients experienced severe hair loss after COVID-19, especially older adults and women.

About 61% of women who had COVID-19 experienced hair loss afterward.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

Standardized definitions and better methods are needed to accurately estimate long COVID-19 prevalence.

Many COVID-19 survivors continue to experience symptoms like fatigue and concentration problems after recovery, possibly needing rehabilitation.

Long COVID causes lasting symptoms and needs ongoing care.

Age, health conditions, race, and gender affect COVID-19 risk.

70.7% of patients had long-COVID symptoms like fatigue, cough, and brain fog three months after recovery.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Most children with MIS-C showed significant improvement by 6 months.

The study identified five types of long COVID symptoms and suggests tailored management strategies for each.

Vaccination and timely treatment reduce the risk of long COVID.

People with blood group O may have a higher risk of developing post-COVID-19 syndrome.

COVID-19 vaccines are safe and highly effective for children, with inactivated vaccines being slightly better.

Women are more likely to have long-term post-COVID symptoms than men.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Marine compounds from gorgonians and soft corals show promise for drug development, especially for chronic disorders.

Adding 25% Brebes shallot powder to wet noodles extends their shelf life and improves flavor but reduces elasticity.

Hair loss is not clearly linked to COVID-19 vaccination in Egyptians.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.